BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13911749)

  • 1. Effects of adenovirus vaccine on acute respiratory disease in U. S. Army recruits.
    SHERWOOD RW; BUESCHER EL; NITZ RE; COOCH JW
    JAMA; 1961 Dec; 178():1125-7. PubMed ID: 13911749
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial of adenovirus vaccine in Royal Air Force recruits.
    WILSON JS; GRANT PJ; MILLER DL; TAYLOR CE; McDONALD JC
    Br Med J; 1960 Apr; 1(5179):1081-3. PubMed ID: 13845090
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of type 21 adenovirus with acute respiratory illness in military recruits.
    VAN DER VEEN J; DIJKMAN JH
    Am J Hyg; 1962 Sep; 76():149-59. PubMed ID: 13925163
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a trivalent adenovirus vaccine for prevention of acute respiratory disease in naval recruits.
    GUNDELFINGER BF; HANTOVER MJ; BELL JA; LOOSLI CG; ROWE WP
    Am J Hyg; 1958 Sep; 68(2):156-68. PubMed ID: 13571230
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of adenovirus vaccine in children with repeated acute respiratory illnesses.
    KOZINN PJ; WIENER H; BURCHALL JJ
    J Pediatr; 1961 Nov; 59():669-73. PubMed ID: 14459097
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine
    Clemmons NS; McCormic ZD; Gaydos JC; Hawksworth AW; Jordan NN
    Emerg Infect Dis; 2017 Jan; 23(1):95-98. PubMed ID: 27748651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOSAGES OF VARIOUS TRIVALENT AND MONOVALENT ADENOVIRUS VACCINES IN THE PROPHLAXIS OF ACUTE RESPIRATORY ILLNESS.
    STILLE WT; HANTOVER MJ
    Am J Hyg; 1964 Jul; 80():121-34. PubMed ID: 14192764
    [No Abstract]   [Full Text] [Related]  

  • 8. Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. (Part I).
    SCHULTZ I; STILLE WT; GUNDELFINGER BF; MILLER LF
    Am J Public Health Nations Health; 1960 Apr; 50(4):543-50. PubMed ID: 14443778
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenovirus vaccine evaluation study in naval recruits.
    LOOSLI CG; TIPTON VC; WARNER O; SMITH M; JOHNSTON PB; HAMRE D
    Proc Soc Exp Biol Med; 1958 Jul; 98(3):583-9. PubMed ID: 13567779
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute respiratory infections in civilian adults. I. Antibody response to polyvalent influenza--adenovirus inactivated vaccine.
    COX F; TIMM EA; QUINN EL; COLVILLE JM; McLEAN IW
    Henry Ford Hosp Med Bull; 1962 Mar; 10():27-33. PubMed ID: 13881896
    [No Abstract]   [Full Text] [Related]  

  • 11. Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. II.
    STILLE WT; SCHULTZ I; GUNDELFINGER BF; MILLER LF
    Am J Public Health Nations Health; 1962 Feb; 52(2):275-89. PubMed ID: 13917238
    [No Abstract]   [Full Text] [Related]  

  • 12. COMPARATIVE EFFECTIVENESS OF 1/2 ML AND 1 ML DOSES OF ADENOVIRUS VACCINE ON RESPIRATORY DISEASE IN NAVY RECRUITS. RES PROJ REP MR 005.09-1203-1.
    PIERCE WE; MILLER LF
    Rep U S Nav Med Res Lab; 1963 Sep; 13():1-11. PubMed ID: 24547139
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits.
    Choudhry A; Mathena J; Albano JD; Yacovone M; Collins L
    Vaccine; 2016 Aug; 34(38):4558-4564. PubMed ID: 27475474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults.
    Sanchez JL; Binn LN; Innis BL; Reynolds RD; Lee T; Mitchell-Raymundo F; Craig SC; Marquez JP; Shepherd GA; Polyak CS; Conolly J; Kohlhase KF
    J Med Virol; 2001 Dec; 65(4):710-8. PubMed ID: 11745936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vaccine: evaluation of antibody response and protective efficacy and comparison with an earlier preparation.
    LENNETTE EH; FLINTJER JD; CULVER JO; FOX VL; STEVENS TE
    Am J Hyg; 1960 Mar; 71():193-203. PubMed ID: 14415712
    [No Abstract]   [Full Text] [Related]  

  • 16. A long-term study of antibody response to an adenovirus vaccine and observations on the effect of concurrent adenovirus disease.
    CULVER JO; LENNETTE EH; FOX VL; FLINTJER JD
    Am J Hyg; 1959 Jan; 69(1):38-48. PubMed ID: 13626943
    [No Abstract]   [Full Text] [Related]  

  • 17. TESTING THE EFFECTIVENESS OF LIVE ADENOVIRUS VACCINE. I. REACTOGENIC PROPERTIES.
    SELIVANOV AA; PLESHANOVA RA; SKRYABINA EA; SMORODINTSEV AA
    Acta Virol; 1964 May; 8():263-70. PubMed ID: 14173474
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant influenza adenovirus vaccine.
    MEIKLEJOHN G
    JAMA; 1962 Feb; 179():594-7. PubMed ID: 14472203
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations.
    HILLEMAN MR
    AMA Arch Intern Med; 1958 Jan; 101(1):47-53. PubMed ID: 13486965
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey.
    van der Veen J; Oei KG; Abarbanel MF
    J Hyg (Lond); 1969 Jun; 67(2):255-68. PubMed ID: 4307899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.